Phase II trial of avibactam/ceftaroline fosamil

Trial Profile

Phase II trial of avibactam/ceftaroline fosamil

Phase of Trial: Phase II

Latest Information Update: 29 Dec 2009

At a glance

  • Drugs Avibactam/ceftaroline fosamil (Primary)
  • Indications Bacterial infections; Systemic inflammatory response syndrome; Urinary tract infections
  • Focus Therapeutic Use
  • Sponsors AstraZeneca; Novexel
  • Most Recent Events

    • 29 Dec 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top